BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 35116832)

  • 1. Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic Sites.
    Tappero S; Piccinelli ML; Incesu RB; Cano Garcia C; Barletta F; Morra S; Scheipner L; Baudo A; Tian Z; Parodi S; Dell'Oglio P; de Cobelli O; Graefen M; Chun FKH; Briganti A; Longo N; Ahyai S; Carmignani L; Saad F; Shariat SF; Suardi N; Borghesi M; Terrone C; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Apr; 22(2):47-55.e2. PubMed ID: 37690970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sites of synchronous distant metastases and prognosis in prostate cancer patients with bone metastases at initial diagnosis: a population-based study of 16,643 patients.
    Zhao F; Wang J; Chen M; Chen D; Ye S; Li X; Chen X; Ren G; Yan S
    Clin Transl Med; 2019 Nov; 8(1):30. PubMed ID: 31784868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study.
    Zhang H; Tan Q; Xiang C; Liu X; Zheng Z
    Gland Surg; 2024 Apr; 13(4):480-489. PubMed ID: 38720678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of prognosis and gene expression in prostate cancer patients with site-specific visceral metastases.
    Zhang P; Chen T; Yang M
    Urol Oncol; 2024 May; 42(5):160.e1-160.e10. PubMed ID: 38433022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors for bone metastases at presentation in solid tumors.
    Knapp BJ; Cittolin-Santos GF; Flanagan ME; Grandhi N; Gao F; Samson PP; Govindan R; Morgensztern D
    Front Oncol; 2024; 14():1392667. PubMed ID: 38800383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eight-year survival and continuation of therapy in a patient suffering from prostate cancer with metastases and pathological fractures of vertebrae.
    Dutkiewicz S; Poniatowska R
    Cent European J Urol; 2011; 64(2):97-9. PubMed ID: 24578875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of advanced stage IV melanoma of unknown primary origin with multiple visceral metastases.
    Liu ET; Hsu CH; Chang DH
    Asian J Surg; 2024 Feb; 47(2):1053-1054. PubMed ID: 37945395
    [No Abstract]   [Full Text] [Related]  

  • 8. From biology to the clinic - exploring liver metastasis in prostate cancer.
    Ni X; Wei Y; Li X; Pan J; Fang B; Zhang T; Lu Y; Ye D; Zhu Y
    Nat Rev Urol; 2024 Apr; ():. PubMed ID: 38671281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of volumetric parameters obtained from
    Güzel Y; Kömek H; Can C; Kaplan İ; Akdeniz N; Kepenek F; Gündoğan C
    Ann Nucl Med; 2023 Sep; 37(9):517-527. PubMed ID: 37332068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Location of Metastases in Contemporary Prostate Cancer Patients Affects Cancer-Specific Mortality.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Soulières D; Graefen M; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2018 Oct; 16(5):376-384.e1. PubMed ID: 29954690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate cancer bone metastases biology and clinical management (Review).
    Archer Goode E; Wang N; Munkley J
    Oncol Lett; 2023 Apr; 25(4):163. PubMed ID: 36960185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic Prostate Cancer to the Optic Canal: A Large-Cohort Analysis.
    Kelkar N; Findakly D; Wang J
    Cureus; 2023 Oct; 15(10):e46598. PubMed ID: 37933347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of developing visceral metastases at diagnosis in prostate cancer patients.
    Xu N; Wu YP; Ke ZB; Liang YC; Tao X; Chen SH; Li XD; Cai H; Lin YZ; Lin TT; Xue XY
    Transl Cancer Res; 2019 Jun; 8(3):928-938. PubMed ID: 35116832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
    Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
    Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors for overall survival in prostate cancer patients with different site-specific visceral metastases: A study of 1358 patients.
    Cui PF; Cong XF; Gao F; Yin JX; Niu ZR; Zhao SC; Liu ZL
    World J Clin Cases; 2020 Jan; 8(1):54-67. PubMed ID: 31970170
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.